«P38 Mitogen-Activated Protein Kinases

Below is an extended P38 Mitogen-Activated Protein Kinases patents listing. Click here to return to the P38 Mitogen-Activated Protein Kinases main in depth entry.

Patents :
US Patent No.	Title
7361633	Screening method and anti-tumor drug candidate obtained therefrom
7259000	Polynucleotides encoding chimeric chemokine receptors
7195902	Phosphatases which activate map kinase pathways
6972298	Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor
6924415	Transgenic mice comprising a constitutively-activated MEK5 and exhibiting cardiac hypertrophy and dilated cardiomyopathy
6900043	Phosphatases which activate map kinase pathways
6410693	Inhibitors of the JNK signal transduction pathway and methods of use
6043083	Inhibitors of the JNK signal transduction pathway and methods of use

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.